Decreased left atrial appendage flow velocity with atrial fibrillation caused by negative inotropic agents: Report of 2 cases

Circulation Journal

Volumn 67, Issue 3, 2003, Pages 277-278

  Kamiyama, Norio ^a   Koyama, Yuji ^a   Suetsuna, Ryouji ^a   Saito, Yasuhiro ^a   Kaji, Shuichiro ^a   Akasaka, Takashi ^a   Yoshida, Kiyoshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atrial fibrillation; Left atrial appendage; Negative inotropic agents; Thromboembolism; Transesophageal echocardiography

Indexed keywords

AMIODARONE; ATENOLOL; ENALAPRIL; FUROSEMIDE; INOTROPIC AGENT; METOPROLOL; PIRMENOL; WARFARIN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CASE REPORT; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART RATE; HEART VENTRICLE; HUMAN; INOTROPISM; MALE; RISK FACTOR; SINUS RHYTHM; THROMBOEMBOLISM;

EID: 0037349707     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.277     Document Type: Article

References (11)

1. Abe Y, Asakura T, Gotou J, Iwai M, Watanabe Y, Sando M, et al. Prediction of embolism in atrial fibrillation: Classification of left atrial thrombi by transesophageal echocardiography. Jpn Circ J 2000; 64: 411-415.
2. Tsai LM, Chen JH, Lin LJ, Teng JK. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol 1997; 80: 897-900.
3. Jones EF, Calafiore P, McNeil JJ, Tonkin AM, Donnan GA. Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke. Am J Cardiol 1996; 78: 425-429.
4. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
6. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128: 639-647.
7. Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991; 84: 223-231.
8. Verhorst PM, Kamp O, Visser CA, Verheugt FW. Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism. Am J Cardiol 1993; 71: 192-196.
9. Toivonen LK, Nieminen MS. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively. Int J Cardiol 1986; 10: 111-118.
10. Wang YP, Takenaka K, Sakamoto T, Amano W, Watanabe F, Igarashi T, et al. Effects of volume loading, propranolol, and heart rate changes on pump function and systolic time intervals of the left atrium in open-chest dogs. Acta Cardiol 1993; 48: 245-262.
11. Goldman S, Olajos M, Morkin E. Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs. J Pharmacol Exp Ther 1982; 222: 270-275.